{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:59:16Z","timestamp":1774263556542,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-82","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T03:44:44Z","timestamp":1360640684000},"source":"Crossref","is-referenced-by-count":85,"title":["Frequent detection of \u2018azole\u2019 resistant Candida species among late presenting AIDS patients in northwest Ethiopia"],"prefix":"10.1186","volume":"13","author":[{"given":"Andargachew","family":"Mulu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afework","family":"Kassu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belay","family":"Anagaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beyene","family":"Moges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aschalew","family":"Gelaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeshambel","family":"Belyhun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fantahun","family":"Biadglegne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zewdu","family":"Hurissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feleke","family":"Moges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Isogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"issue":"Suppl 2","key":"2268_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1034\/j.1601-0825.8.s2.6.x","volume":"23","author":"LP Samaranayake","year":"2002","unstructured":"Samaranayake LP, Fidel PL, Naglik JR: Fungal infections associated with HIV infection. Oral Dis. 2002, 23 (Suppl 2): 151-160.","journal-title":"Oral Dis"},{"key":"2268_CR2","first-page":"180","volume":"22","author":"E Diro","year":"2008","unstructured":"Diro E, Feleke Y, Guteta S, Fekade D, Neway M: Assessment of Risk Behaviours and Factors Associated with Oral and Peri-oral Lesions in Adult HIV Patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop J Health Dev. 2008, 22: 180-186.","journal-title":"Ethiop J Health Dev"},{"key":"2268_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1034\/j.1600-0714.2002.310102.x","volume":"31","author":"J Campo","year":"2002","unstructured":"Campo J, Del Romero J, Castilla J, Garcia S, Rodriguez C, Bascones A: Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med. 2002, 31: 5-10. 10.1034\/j.1600-0714.2002.310102.x.","journal-title":"J Oral Pathol Med"},{"key":"2268_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6831-6-12","volume":"6","author":"FHM Mikx","year":"2006","unstructured":"Mikx FHM, Verweij PE, van der Ven AJAM: Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006, 6: 12-10.1186\/1472-6831-6-12.","journal-title":"BMC Oral Health"},{"key":"2268_CR5","volume-title":"New report on global problem of oral diseases","author":"WHO","year":"2004","unstructured":"WHO: New report on global problem of oral diseases. 2004, Geneva, http:\/\/www.who.int\/mediacentre\/news\/releases\/2004\/pr15\/en\/ ,"},{"issue":"Suppl 1","key":"2268_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","volume":"10","author":"JA Maertens","year":"2004","unstructured":"Maertens JA: History of the development of azole derivatives. Clin Microbiol Infect. 2004, 10 (Suppl 1): 1-10.","journal-title":"Clin Microbiol Infect"},{"key":"2268_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S1201-9712(02)90072-X","volume":"6","author":"AL Colombo","year":"2002","unstructured":"Colombo AL, Da Matta D, De Almeida LP, Rosas R: Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method. J Infect Dis. 2002, 6: 118-123. 10.1016\/S1201-9712(02)90072-X.","journal-title":"J Infect Dis"},{"key":"2268_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2180-8-135","volume":"8","author":"O Hamza","year":"2008","unstructured":"Hamza O, Matee M, Moshi M: Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008, 8: 135-10.1186\/1471-2180-8-135.","journal-title":"BMC Microbiol"},{"key":"2268_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/ijsa.2010.010140","volume":"21","author":"A Mulu","year":"2010","unstructured":"Mulu A, Diro E, Tekleselassie H: Effect of Ethiopian multiflora honey on fluconazole-resistant Candida species isolated from the oral cavity of AIDS patients. Int J STD AIDS. 2010, 21: 1-5. 10.1258\/ijsa.2010.10w001.","journal-title":"Int J STD AIDS"},{"key":"2268_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/jac\/46.2.338","volume":"46","author":"FMC M\u00fcller","year":"2000","unstructured":"M\u00fcller FMC, Weig M, Peter J, Walsh TJ: Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J Antimicrob Chemother. 2000, 46: 338-341. 10.1093\/jac\/46.2.338.","journal-title":"J Antimicrob Chemother"},{"key":"2268_CR11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/JCM.38.4.1563-1568.2000","volume":"38","author":"R Pelletier","year":"2000","unstructured":"Pelletier R, Peter J, Antin C, Gonzalez C, Wood L, Walsh TJ: Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: In vitro and clinical correlations. J Clin Microbiol. 2000, 38: 1563-1568.","journal-title":"J Clin Microbiol"},{"key":"2268_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5455\/jeim.260911.or.012","volume":"1","author":"N Wabe","year":"2011","unstructured":"Wabe N, Hussein J, Suleman S, Abdella K: In vitro antifungal susceptibility of Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus in Ethiopia. J Exp Integr Med. 2011, 1: 265-271.","journal-title":"J Exp Integr Med"},{"key":"2268_CR13","first-page":"235","volume":"36","author":"Y Woldeamanuel","year":"1998","unstructured":"Woldeamanuel Y, Abate D: Characterization of C. albicans isolates from the oral cavity of HIV positive patients. Ethiop Med J. 1998, 36: 235-243.","journal-title":"Ethiop Med J"},{"key":"2268_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1754-4505.2000.tb00015.x","volume":"20","author":"SW Redding","year":"2000","unstructured":"Redding SW, Kirpatrick WR, Dib O, Fothergill AW, Rinaldi MG, Patterson TF: The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dentist. 2000, 20: 178-181. 10.1111\/j.1754-4505.2000.tb00015.x.","journal-title":"Spec Care Dentist"},{"key":"2268_CR15","unstructured":"Guidelines for management of opportunistic infections and antiretroviral treatment in adolescents and adults in Ethiopia. 2007, Addis Ababa Ethiopia: Federal HIV\/AIDS Prevention and Control Office Federal Ministry of Health"},{"key":"2268_CR16","unstructured":"Standard treatment guideline. 2004, Addis Ababa: Drug Administration and Control authority, Ministry of Health"},{"key":"2268_CR17","first-page":"1","volume":"10","author":"H Isogai","year":"2010","unstructured":"Isogai H, Mulu A, Diro E: Identification of Candida species from Human Immunodeficiency Virus-infected Patients in Ethiopia by Combination of CHROMagar, Tobacco agar and PCR of Amplified Internally Transcribed rRNA Spacer Region. J Appl Res. 2010, 10: 1-7.","journal-title":"J Appl Res"},{"key":"2268_CR18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/JCM.12.3.475-476.1980","volume":"12","author":"JB Epstein","year":"1980","unstructured":"Epstein JB, Pearsall NN, Truelove EL: Quantitative relationship between Candida albicans and the clinical status of human subjects. J Clin Microbiol. 1980, 12: 475-476.","journal-title":"J Clin Microbiol"},{"key":"2268_CR19","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd ed. M27-A3","author":"CLSI","year":"2008","unstructured":"CLSI: Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd ed. M27-A3. 2008, Wayne, PA: Clinical and Laboratory Standards Institute"},{"key":"2268_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF02915247","volume":"172","author":"JE Moore","year":"2003","unstructured":"Moore JE, MC Mullan R: Comparison of media for optimal recovery of Candida albicans and Candida glabrata from blood culture. Irish Med J. 2003, 172: 60-62. 10.1007\/BF02915247.","journal-title":"Irish Med J"},{"key":"2268_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1590\/S1806-83242011005000001","volume":"25","author":"GN Brito","year":"2010","unstructured":"Brito GN, Inoc\u00eancio AC, Querido SM: In vitro antifungal susceptibility of Candida spp. oral isolates from HIV positive patients and control individuals. Braz Oral Res. 2010, 25: 28-33.","journal-title":"Braz Oral Res"},{"key":"2268_CR22","first-page":"605","volume":"54","author":"E Blignaut","year":"1999","unstructured":"Blignaut E, Botes M, Nieman H: The treatment of oral candidiasis in a cohort of South African HIV\/AIDS patients. SADJ. 1999, 54: 605-608.","journal-title":"SADJ"},{"key":"2268_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0732-8893(02)00440-6","volume":"44","author":"E Blignaut","year":"2002","unstructured":"Blignaut E, Messer S, Hollis RJ, Pfaller MA: Antifungal susceptibility of South African oral yeast isolates from HIV\/AIDS patients and healthy individuals. Diagn Microbiol Infec Dis. 2002, 44: 169-174. 10.1016\/S0732-8893(02)00440-6.","journal-title":"Diagn Microbiol Infec Dis"},{"key":"2268_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11046-006-0087-9","volume":"163","author":"E Blignaut","year":"2007","unstructured":"Blignaut E: Oral candidiasis and oral yeast carriage among institutionalized South African paediatric HIV\/AIDS patients. Mycopathologia. 2007, 163: 67-73. 10.1007\/s11046-006-0087-9.","journal-title":"Mycopathologia"},{"key":"2268_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/jac\/43.3.419","volume":"43","author":"JD Cartledge","year":"1999","unstructured":"Cartledge JD, Middle J, Gazzard BG: Non-albicans oral candidosis in HIV-positive patients. J Antimicrob Chemother. 1999, 43: 419-422. 10.1093\/jac\/43.3.419.","journal-title":"J Antimicrob Chemother"},{"key":"2268_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00436507","volume":"112","author":"CR Paula","year":"1990","unstructured":"Paula CR, Sampaio MC, Birman EG, Siqueira AM: Oral yeasts in patients with cancer of the mouth, before and during radiotherapy. Mycopathologia. 1990, 112: 119-124. 10.1007\/BF00436507.","journal-title":"Mycopathologia"},{"key":"2268_CR27","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1099\/mic.0.2007\/010405-0","volume":"153","author":"RD Cannon","year":"2007","unstructured":"Cannon RD, Lamping E, Holmes AR, Niimi K, Tanabe K, Niimi M, Monk BC: Candida albicans drug resistance-another way to cope with stress. Microbiology. 2007, 153: 3211-3217. 10.1099\/mic.0.2007\/010405-0.","journal-title":"Microbiology"},{"key":"2268_CR28","first-page":"466","volume":"4","author":"D Satana","year":"2010","unstructured":"Satana D, Gonca Erkose Genc , Erturan Z: The antifungal susceptibilities of oral Candida spp isolates from HIV-infected patients. Afr J Microbiol Res. 2010, 4: 466-470.","journal-title":"Afr J Microbiol Res"},{"key":"2268_CR29","first-page":"125","volume":"44","author":"A Mulu","year":"2006","unstructured":"Mulu A, Moges F, Tessema B, Kassu A: Pattern and multiple drug resistance of bacterial pathogens isolated from wound infection at University of Gondar Teaching Hospital, Northwest Ethiopia. Ethiop Med J. 2006, 44: 125-131.","journal-title":"Ethiop Med J"},{"key":"2268_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/clinids\/18.2.240","volume":"18","author":"S Redding","year":"1994","unstructured":"Redding S, Smith J, Farinacci G, Rinaldi M, Fothergill A, Rhine-Chalberg J, Pfaller M: Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis. 1994, 18: 240-242. 10.1093\/clinids\/18.2.240.","journal-title":"Clin Infect Dis"},{"key":"2268_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11046-005-6873-y","volume":"160","author":"C Hartung de Capriles","year":"2005","unstructured":"Hartung de Capriles C, Mata-Essayag S, P\u00e9rez C, Colella MT, Rosell\u00f3 A, Olaizola C, Abate SM: Detection of Candida dubliniensis in Venezuela. Mycopathologia. 2005, 160: 227-234. 10.1007\/s11046-005-6873-y.","journal-title":"Mycopathologia"},{"key":"2268_CR32","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1128\/AAC.44.6.1585-1587.2000","volume":"44","author":"M Goldman","year":"2000","unstructured":"Goldman M, Cloud GA, Smedema M, LeMonte A, Connolly P, McKinsey DS, Kauffman CA, Moskovitz B, Wheat LJ: Does long-term itraconazole prophylaxis result in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?. Antimicrob Agents Chemother. 2000, 44: 1585-1587. 10.1128\/AAC.44.6.1585-1587.2000.","journal-title":"Antimicrob Agents Chemother"},{"key":"2268_CR33","first-page":"142","volume":"8","author":"CA Enwuru","year":"2008","unstructured":"Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M: Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci. 2008, 8: 142-148.","journal-title":"Afr Health Sci"},{"key":"2268_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0732-8893(98)00160-6","volume":"33","author":"MA Pfaller","year":"1999","unstructured":"Pfaller MA, Messer SA, Hollis RJ, Jones JN: Trends in Species distribution and Susceptibility to fluconazole among blood Stream Isolates of Candida species in the United States. Diagn Microbiol Infect Dis. 1999, 33: 217-222. 10.1016\/S0732-8893(98)00160-6.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2268_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1590\/S1517-83822008000400013","volume":"39","author":"JP Lyon","year":"2008","unstructured":"Lyon JP, Moreira LM, Cardoso MAG, Saade J, Resende MA: Antifungal susceptibility profile of Candida spp. oral isolates obtained from denture wearers. Braz J Microbiol. 2008, 39: 668-672. 10.1590\/S1517-83822008000400013.","journal-title":"Braz J Microbiol"},{"key":"2268_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.diagmicrobio.2008.05.007","volume":"62","author":"R Rautemaa","year":"2008","unstructured":"Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Sax\u00e9n H: Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis. Diagn Microbiol Infect Dis. 2008, 62: 182-185. 10.1016\/j.diagmicrobio.2008.05.007.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 1","key":"2268_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijantimicag.2006.03.012","volume":"27","author":"TR Rogers","year":"2006","unstructured":"Rogers TR: Antifungal drug resistance: limited data, dramatic impact?. Int J Antimicrob Agents. 2006, 27 (Suppl 1): 7-11.","journal-title":"Int J Antimicrob Agents"},{"key":"2268_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1590\/S0037-86822007000300004","volume":"40","author":"MA Wingeter","year":"2007","unstructured":"Wingeter MA, Guilhermetti E, Shinobu CS, Takaki I, Svidzinski TIE: Identifica\u00e7\u00e3o microbiol\u00f3gica e sensibilidade in vitro de Candida isoladas da cavidade oral de indiv\u00edduos HIV positivos. Rev Soc Bras Med Trop. 2007, 40: 272-276. 10.1590\/S0037-86822007000300004.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2268_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0255-0857(21)02345-8","volume":"24","author":"S Khan","year":"2006","unstructured":"Khan S, Singhal S, Mathur T, Upadhyay DJ, Rattan A: Antifungal susceptibility testing method for resource constrained laboratories. Indian J Med Microbiol. 2006, 24: 171-176.","journal-title":"Indian J Med Microbiol"},{"key":"2268_CR40","first-page":"107","volume":"17","author":"E Manavathu","year":"2000","unstructured":"Manavathu E, Nune U, Kanuri K, Chandrasekar P, Abraham O: Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus. Rev Iberoam Micol. 2000, 17: 107-110.","journal-title":"Rev Iberoam Micol"},{"key":"2268_CR41","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1128\/AAC.01313-10","volume":"55","author":"L Yu","year":"2011","unstructured":"Yu L, Ling G, Deng X, Jin J, Jin Q, Guo N: In Vitro Interaction between fluconazole and triclosan against clinical isolates of fluconazole-Resistant Candida albicans determined by different methods. Antimicrob Agents Chemother. 2011, 55: 3609-3612. 10.1128\/AAC.01313-10.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-82\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T12:34:16Z","timestamp":1644323656000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-82","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]},"article-number":"82"}}